Business
Wanda Awarded US Patent
Wanda Awarded US Patent.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 3409S NetScientific PLC 02 October 2017 \n\nNetScientific plc\n(\"NetScientific\" or the \"Company\" or the \"Group\")\n \nWanda Awarded US Patent which Extends Protection across the US \n \n \nLondon, UK - October 2nd 2017 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces the issue by the U.S. Patent and Trademark Office of a new patent exclusively licensed to its portfolio company, Wanda. The patent will significantly extend protection for the core technology used in Wanda's software application for remote health and patient management. The patent, titled, \"Context-aware prediction in medical systems\" is among the technologies developed at UCLA which aim to better assess and predict medical events by defining and using contextual data on top of medical information.\n \nCommenting on the news, NetScientific's Chief Executive Officer and Chairman of Wanda, Francois R. Martelet said: \"We are delighted to announce this strengthening of the IP landscape for Wanda, which represents an important step for Wanda's organisational development. We believe Wanda's class leading predictive and behavioural analytics platform acts as a competitive differentiator in the emerging and highly exciting Digital Health sector.\"\n \nNetScientific holds a 61% stake on a fully diluted basis in Wanda.\n \nFor more information, please contact:\n \n\n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott Jessica Hodgson /\n Chris Welsh / Laura Thornton \n \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nStifel Nicolaus Europe Limited (NOMAD and Broker)\nJonathan Senior / David Arch / Ben Maddison\n\n\n Tel: +44 (0) 20 7710 7600\n\n\n\n\n \n \nAbout NetScientific \n \nNetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net\n \nAbout Wanda\n ...